IL300578A - A new oral contraceptive with a different release - Google Patents

A new oral contraceptive with a different release

Info

Publication number
IL300578A
IL300578A IL300578A IL30057823A IL300578A IL 300578 A IL300578 A IL 300578A IL 300578 A IL300578 A IL 300578A IL 30057823 A IL30057823 A IL 30057823A IL 300578 A IL300578 A IL 300578A
Authority
IL
Israel
Prior art keywords
composition
contraceptive
oral
dng
release
Prior art date
Application number
IL300578A
Other languages
English (en)
Hebrew (he)
Original Assignee
Chemo Res S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Res S L filed Critical Chemo Res S L
Publication of IL300578A publication Critical patent/IL300578A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
IL300578A 2020-08-14 2021-08-13 A new oral contraceptive with a different release IL300578A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20382753.0A EP3954364A1 (en) 2020-08-14 2020-08-14 New modified release oral contraceptive composition
PCT/EP2021/072584 WO2022034209A1 (en) 2020-08-14 2021-08-13 New modified release oral contraceptive composition

Publications (1)

Publication Number Publication Date
IL300578A true IL300578A (en) 2023-04-01

Family

ID=72145348

Family Applications (1)

Application Number Title Priority Date Filing Date
IL300578A IL300578A (en) 2020-08-14 2021-08-13 A new oral contraceptive with a different release

Country Status (21)

Country Link
US (3) US12409141B2 (enExample)
EP (2) EP3954364A1 (enExample)
JP (1) JP2023538030A (enExample)
KR (1) KR20230067614A (enExample)
CN (1) CN116322701A (enExample)
AU (1) AU2021325372A1 (enExample)
BR (1) BR112023002654A2 (enExample)
CA (1) CA3191326A1 (enExample)
CL (1) CL2023000450A1 (enExample)
CO (1) CO2023002874A2 (enExample)
CR (1) CR20230127A (enExample)
DO (1) DOP2023000029A (enExample)
EC (1) ECSP23016038A (enExample)
IL (1) IL300578A (enExample)
JO (1) JOP20230032A1 (enExample)
MX (1) MX2023001868A (enExample)
PE (1) PE20231378A1 (enExample)
PY (1) PY2168235A (enExample)
UY (1) UY39379A (enExample)
WO (1) WO2022034209A1 (enExample)
ZA (1) ZA202303273B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20260021110A1 (en) * 2024-07-18 2026-01-22 Chemo Research, S.L. Methods of oral contraception by controlled release of dienogest and ethynyl estradiol
WO2026146125A1 (en) 2024-12-30 2026-07-09 Chemo Research, S.L. Treatment of hirsutism, polycystic ovarian syndrome and other associated conditions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340585A (en) 1991-04-12 1994-08-23 University Of Southern California Method and formulations for use in treating benign gynecological disorders
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
US7589082B2 (en) 2003-06-13 2009-09-15 Skendi Finance Ltd Pharmaceutical formulation for contraception and hormone-replacement therapy
EP1690529A1 (de) 2005-02-15 2006-08-16 Schering AG Feste perorale Arzneiform zur Kontrazeption, die Dienogest und Ethinylestradiol enthält
DK1848406T3 (da) * 2005-02-15 2008-09-15 Jenapharm Gmbh Fast, penoral lægemiddelform til kontraception, der indeholder dienogest og ethynylestradiol
DE102005034498A1 (de) * 2005-07-20 2007-01-25 Grünenthal GmbH Orale Kontrazeption mit Trimegeston
TW201008569A (en) * 2008-08-08 2010-03-01 Bayer Schering Pharma Ag Progestin-containing drug delivery system

Also Published As

Publication number Publication date
UY39379A (es) 2022-01-31
CO2023002874A2 (es) 2023-04-05
CR20230127A (es) 2023-06-23
MX2023001868A (es) 2023-05-09
CN116322701A (zh) 2023-06-23
US12409141B2 (en) 2025-09-09
DOP2023000029A (es) 2023-07-09
PE20231378A1 (es) 2023-09-07
US20260027058A1 (en) 2026-01-29
AU2021325372A1 (en) 2023-03-30
EP3954364A1 (en) 2022-02-16
US12409142B2 (en) 2025-09-09
CL2023000450A1 (es) 2023-10-20
WO2022034209A1 (en) 2022-02-17
JOP20230032A1 (ar) 2023-02-13
ECSP23016038A (es) 2023-04-28
EP4196098A1 (en) 2023-06-21
JP2023538030A (ja) 2023-09-06
US20240041775A1 (en) 2024-02-08
BR112023002654A2 (pt) 2023-04-04
ZA202303273B (en) 2026-02-25
PY2168235A (es) 2022-04-25
US20240350415A1 (en) 2024-10-24
CA3191326A1 (en) 2022-02-17
KR20230067614A (ko) 2023-05-16

Similar Documents

Publication Publication Date Title
US11291632B2 (en) Synthetic progestogens and pharmaceutical compositions comprising the same
US11478487B1 (en) Synthetic progestogens and pharmaceutical compositions comprising the same
US20260027058A1 (en) New modified release oral contraceptive composition
US12478630B2 (en) Method for treating endometriosis and providing effective contraception
PL199848B1 (pl) Zastosowanie estrogeno-progestagenowego połączenia w dziedzinie terapii hormonalnej
JP5484646B2 (ja) 新規な避妊薬とその調製方法
US20260021110A1 (en) Methods of oral contraception by controlled release of dienogest and ethynyl estradiol
OA21171A (en) New modified release oral contraceptive composition.
HK40096856A (en) New modified release oral contraceptive composition
BR122025022756A2 (pt) Composição contraceptiva oral de liberação modificada, seu uso, seu processo de obtenção e kit contraceptivo
KR102210982B1 (ko) 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트
AU2022320019A1 (en) Progestogen-only oral contraception
HK40111725A (en) Method for treating endometriosis and providing effective contraception
CN106265694A (zh) 用于过重女性患者的基于屈螺酮的避孕药